[1]
“Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis”, Arch Ital Urol Androl, vol. 95, no. 2, Jun. 2023, doi: 10.4081/aiua.2023.11509.